Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • rikkomba
    Junior Member
    • Oct 2009
    • 4

    [ChIP-seq] MACS 1.4: assertion error

    HI,

    I just started working with ChIP-seq and I am using MACS to predict binding sites for a fungal genome (12MB).
    As mentioned here, I am getting the same problem as some previous users: I get an assertion error when calculating negative peaks, and I only managed to solve the problem by reducing the amount of data to 75%, i.e. if the amount of reads goes to 80% or more of the original amount, I will get the error again.

    I have a control file with 31M 36bp single reads (4.1GB) and a sample file
    with 28M 36bp single reads (3.6GB).
    I tried it both a laptop (4GB RAM) and a server (16GB RAM), in
    both cases it was using 1.6GB of memory and was behaving the same way. I also tried it on Cistrome, idem.
    Changing the mfold parameter didn't help.
    With 75% of the data I did get sensible results, but I am not sure how can I move on discarding 25% of a dataset... it just adds another layer of complexity to the analysis.

    Does anybody have an idea of the cause of the problem, and of the reason
    why reducing the amount of data works?
    Also, if anybody knows any alternative, valid tool, feel free to suggest
    Thanks!
  • taoliu
    Junior Member
    • Sep 2009
    • 3

    #2
    I just answered this question in MACS user group, however, since you asked in seqanswer, I re-post it here.


    This error normally happens when you have too many reads in a very small genome. In your case, you use a whole GA2 lane to sequence a single factor in a genome like E coli. Then due to the extremely high coverage, this overflow error occurs since my function doesn't expect a poisson rate higher than 740...

    In practice, you'd better consider using multiplex to fully use a single lane to sequence multiple factors or a single factor in multiple conditions/time points. 30million reads for a single experiment on a 4million genome is a big waste -- you can even assemble the genome for this species now...

    Anyway, since you have already got your 30millions reads, what you can do ( instead of waiting me to fix it (: ) is to subsample your sequencing reads. My impression for human chip-seq, if you want to reach saturation for peak detection, you need about 300 million reads ( from our unpublished Nat Method paper ) which is equivalent to 0.5million reads in E coli . You can use "samtools view -s" to subsample a portion of your BAM file.
    梦蝶

    Comment

    • rikkomba
      Junior Member
      • Oct 2009
      • 4

      #3
      Thanks for the explanation! I ll try with downsampling, then.

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Yesterday, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...